Last reviewed · How we verify
NCT03514654: MIAMI
MIAMI Safe Surgery for Multiple Breast Cancers
NA trial testing Mastectomy in Breast Cancer, Unilateral in 4 participants. Completed in 31 October 2020.
31 October 2020
Quick facts
| Lead sponsor | University College, London |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 4 |
| Start date | 1 November 2017 |
| Primary completion | 31 October 2020 |
| Estimated completion | 31 October 2020 |
| Sites | 7 locations across United Kingdom |
Drugs / interventions tested
- Mastectomy
- Therapeutic Mammoplasty
Conditions studied
- Breast Cancer, Unilateral — all drugs for Breast Cancer, Unilateral →
Sponsor
University College, London
Who can join
40 and older, female only, with Breast Cancer, Unilateral. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sometimes women have more than one breast cancer in the same breast at the same time. These women are usually offered a mastectomy (removal of that breast) and breast reconstruction. It may be possible to treat these patients by removing each cancer using breast-saving surgery (lumpectomies), used for women with only one breast cancer. Databases show that women who had lumpectomies did well, but they may have been healthier before the surgery than those who had a mastectomy. The investigators need to be sure that lumpectomy is effective, safe, and acceptable for this patient group before making it universally available.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The challenge of equipoise: qualitative interviews exploring the views of health professionals and women with multiple ipsilateral breast cancer on recruitment to a surgical randomised controlled feasibility trial.
Ingram J, Beasant L, Benson J, Brunt AM, et al · · 2022 · cited 9× · PMID 35227311 · DOI 10.1186/s40814-022-01007-1 -
The Challenge of Equipoise: Qualitative Interviews Exploring the Views of Health Professionals and Women With Multiple Ipsilateral Breast Cancer in a Surgical Randomised Controlled Trial.
Ingram J, Beasant L, Benson J, Brunt AM, et al · · 2021 · DOI 10.21203/rs.3.rs-386168/v2
Verify or expand the search:
- PubMed search for NCT03514654
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mastectomy
Trials testing the same drug.
- NCT06704659 — Study on Recurrent Breast Cancer and Repeated Radiation Therapy · NA · recruiting
- NCT06425874 — The Impact of Socioeconomic Determinants on the Patient Reported Outcomes in Young Breast Cancer Patients After Breast S · recruiting
- NCT06103032 — Survival of BCS vs Mx in Asymptomatic Screen-detected NPBC · completed
- NCT06130111 — Spatial Location of Breast Cancer Local Recurrence After Mastectomy · unknown
- NCT06378294 — Locoregional Control With Radiotherapy of Breast Cancer Patients With MACrometastases Treated With MAstectomy (MACMA) · active not recruiting
Other University College, London trials
Trials by the same sponsor.
- NCT07386652 — Intensive Comprehensive Aphasia Programme for People With Post-Stroke Aphasia · NA · not yet recruiting
- NCT06924086 — The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial · NA · recruiting
- NCT07386678 — Study of Imaging and Molecular Biomarkers in Uncomplicated Rhegmatogenous Retinal Detachment · not yet recruiting
- NCT07414940 — ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium · Phase 1, PHASE2 · not yet recruiting
- NCT07214454 — TCDS for the Treatment of Chronic Migraine · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03514654 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University College, London
- Last refreshed: 18 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03514654.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing